Clinical Trials Directory

Trials / Completed

CompletedNCT07341607

STRUCTURED PATIENT EDUCATION IN ESWL PATIENTS

Effect of Structured Patient Education on Anxiety Levels and Quality of Life in Patients Undergoing Extracorporeal Shock Wave Lithotripsy: A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
188 (actual)
Sponsor
KTO Karatay University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Urolithiasis is a common urological disease with an increasing prevalence and high recurrence rates, negatively affecting patients' quality of life. Extracorporeal shock wave lithotripsy is a frequently preferred non-invasive treatment option in appropriate cases; however, uncertainties related to the procedural process and inadequate patient information may lead to increased anxiety and a decline in quality of life. Structured patient education delivered under nurse leadership has emerged as a potential approach to mitigate these adverse effects. Nevertheless, studies evaluating the impact of structured patient education on anxiety levels and quality of life in patients undergoing extracorporeal shock wave lithotripsy remain limited.

Conditions

Interventions

TypeNameDescription
OTHERIntervention GroupIntervention Group Patients in the intervention group will receive a nurse-led structured patient education program covering both the pre- and post-extracorporeal shock wave lithotripsy (ESWL) periods. The education program has been developed in accordance with the current urolithiasis guidelines published by the European Association of Urology (Skolarikos et al., 2025) and the American Urological Association (Akram et al., 2024), as well as relevant up-to-date scientific literature (Geraghty et al., 2023; Jiang et al., 2021; Kasab et al., 2023; Koudonas et al., 2025; Tzelves et al., 2021).

Timeline

Start date
2025-09-25
Primary completion
2026-01-01
Completion
2026-01-06
First posted
2026-01-14
Last updated
2026-01-14

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07341607. Inclusion in this directory is not an endorsement.